Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Balancing Ischemic and Bleeding Risks of Prolonged Dual Antiplatelet Therapy.

Literature DB >> 28697242

Balancing Ischemic and Bleeding Risks of Prolonged Dual Antiplatelet Therapy.

Glenn N Levine¹.

Abstract

Mesh：

Substances：

Year: 2017 PMID： 28697242 DOI： 10.1001/jama.2017.6698

Source DB: PubMed Journal: JAMA ISSN： 0098-7484 Impact factor: 56.272

Keyword Cloud
Cited

× No keyword cloud information.

1 in total

1. DT-678 inhibits platelet activation with lower tendency for bleeding compared to existing P2Y₁₂ antagonists.

Authors: Dale A Lauver; Dawn S Kuszynski; Barbara D Christian; Matthew P Bernard; James P Teuber; Bruce E Markham; Yuqing E Chen; Haoming Zhang
Journal: Pharmacol Res Perspect Date: 2019-07-25

1 in total

Balancing Ischemic and Bleeding Risks of Prolonged Dual Antiplatelet Therapy.

1. DT-678 inhibits platelet activation with lower tendency for bleeding compared to existing P2Y12 antagonists.

1. DT-678 inhibits platelet activation with lower tendency for bleeding compared to existing P2Y₁₂ antagonists.